May 13, 2021

Winning the War on Huntington’s Disease

Date and time

May 13, 2021 ~ May 13, 2021

In honoring Huntington’s Disease Awareness Month, WuXi AppTec is proud to host the “Winning the War on Huntington’s Disease” webinar to raise awareness and increase understanding of this rare and devastating, hereditary neurodegenerative disease.


This complimentary webinar is the sixth in WuXi AppTec’s ongoing “Collaborations That Transform” series, where we will convene drug developers, physicians, patients, and advocates to critically examine the state of treatment and care, and how to forge ahead with resilience and collaborative new approaches despite recent setbacks.


At WuXi AppTec, we deeply believe that we must work collaboratively to solve industry-wide challenges and bring transformative medicines to patients worldwide.

Agenda
  • 08:00 AM - 08:05 AM Welcome

    Hui Cai, Program Chair, VP and Head of Content, WuXi AppTec

  • 08:05 AM - 08:30 AM Huntington’s Disease: Challenges, Lessons, and Opportunities

    Michael Hayden, Founder & CEO, Prilenia Therapeutics; Killam Professor at the University of British Columbia

    Moderator: Michael Ward, Global Head of Life Sciences & Healthcare Thought Leadership, Clarivate

  • 08:30 AM - 09:20 AM The Evolving Landscape of Care in Huntington’s Disease

    Karen Anderson, Professor, Psychiatry & Neurology, Georgetown University; Director, HD Care, Education and Research Center

    Blair Leavitt, Professor, Department of Medical Genetics and Senior Scientist, Centre for Molecular Medicine and Therapeutics, UBC

    Svein Olaf Osen, President, International Huntington Association

    Kristen Powers, Executive Producer, Twitch

    Moderator: Richard Soll, Head of Boston Office and Senior Advisor of Strategic Initiatives, WuXi AppTec

  • 09:20 AM - 10:00 AM New Modalities and Technologies Driving Progress in Huntington’s Disease

    Irina Antonijevic, CMO, Triplet Therapeutics

    Ricardo Dolmetsch, President, Research & Development, uniQure

    Aimee Jackson, CSO, Atalanta Therapeutics

    Moderator: Dave Madge, VP, Research Service Division, WuXi AppTec

Speakers
  • Hui Cai
    Hui Cai
    Program Chair, VP and Head of Content, WuXi AppTec
  • Michael Hayden
    Michael Hayden
    Founder & CEO, Prilenia Therapeutics; Killam Professor at the University of British Columbia
  • Michael Ward
    Michael Ward
    Global Head of Life Sciences & Healthcare Thought Leadership, Clarivate
  • Karen Anderson
    Karen Anderson
    Professor, Psychiatry & Neurology, Georgetown University; Director, HD Care, Education and Research Center
  • Blair Leavitt
    Blair Leavitt
    Professor, Department of Medical Genetics and Senior Scientist, Centre for Molecular Medicine and Therapeutics, UBC
  • Svein Olaf Osen
    Svein Olaf Osen
    President, International Huntington Association
  • Kristen Powers
    Kristen Powers
    Executive Producer, Twitch
  • Richard Soll
    Richard Soll
    Head of Boston Office and Senior Advisor of Strategic Initiatives, WuXi AppTec
  • Irina Antonijevic
    Irina Antonijevic
    CMO, Triplet Therapeutics
  • Ricardo Dolmetsch
    Ricardo Dolmetsch
    President, Research & Development, uniQure
  • Aimee Jackson
    Aimee Jackson
    CSO, Atalanta Therapeutics
  • Dave Madge
    Dave Madge
    VP, Research Service Division, WuXi AppTec

EVENTS

wuxi-executive-breakfast-in-basel-the-most-important-innovation-in-drug-r-d-may-be-how-the-industry-works-together
WuXi Executive Breakfast in Basel: The Most Important Innovation in Drug R&D May Be How the Industry Works Together
Reflections from the WuXi Executive Breakfast at Swiss Biotech Day
May 11, 2026
READ MORE

FEATURED

© 2026 WuXi AppTec. All Rights Reserved.Privacy Policy